TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

AZN $46.18 -$0.28

at close on MONDAY

By The Associated Press
Tuesday, March 19, 2013, 12:01 a.m.
 

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Federal appeals courts disagree on Obamacare subsidies
  2. Toyota follows hybrid success with gamble on fuel cell technology
  3. Latrobe’s Ci Medical Technologies transforms to medical device business
  4. Allegheny Technologies reports 2Q loss despite higher sales
  5. Gas pipeline issues challenge for producers, users
  6. U.S. stocks slip to start the week; Six Flags sinks
  7. Grads’ starting salaries way behind average
  8. Congress may crimp offshore merger tax relief
  9. AK Steel to acquire Severstal plant in Michigan for $700M
  10. U.S. companies report rising sales, employment in 2Q
  11. Checking account holdings reach 25-year high
Subscribe today! Click here for our subscription offers.